Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease--research or clinical application?
- PMID: 7588985
- PMCID: PMC7101983
- DOI: 10.1007/BF02155101
Surfactant replacement therapy for non-respiratory distress syndrome neonatal respiratory disease--research or clinical application?
Abstract
Research studies have highlighted both physiological and pathological evidence to incriminate surfactant abnormality and/or deficiency in many neonatal respiratory diseases. Data from animal models and clinical studies support the concept that surfactant replacement therapy (SRT) may have a role to play in such problems. There is now, therefore, a need to perform further randomized controlled trials to assess the appropriate clinical application of SRT in non-respiratory distress syndrome neonatal respiratory disease.
References
-
- Auten RL, Notter RH, Kendig JW, Davis JM, Shapiro DL. Surfactant treatment of full term newborns with respiratory failure. Pediatrics. 1991;87:101–107. - PubMed
-
- Bakeer Al-Mateen K, Dailey K, Grimes MM, Gutcher GR. Improved oxygenation with exogenous surfactant administration in experimental meconium aspiration syndrome. Pediatr Pulmonol. 1994;17:75–80. - PubMed
-
- Brown DL, Pattishall EN. Other uses of surfactant. Clin Perinatol. 1993;20:761–789. - PubMed
-
- Bui KC, Walther FJ, David CuR, Garg M, Warburton D. Phospholipid and surfactant protein A concentrations in tracheal aspirates from infants requiring extracorporeal membrane oxygenation. J Pediatr. 1992;121:271–274. - PubMed
-
- Glick PL, Leach CL, Besner GE, Egan EA, Morin FC, et al. Pathophysiology of congenital diaphragmatic hernia III: exogenous surfactant therapy for the high risk neonate with CDH. J Pediatr Surg. 1992;27:866–869. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources